Pneumococcal vaccine in patients with systemic juvenile idiopathic arthritis receiving biologic therapy: International practice review [Вакцинация...
Алексеева Е. И., Ван’кова Д. Д., Солошенко М. А., Дворяковская Т. М., Исаева К. Б., Денисова Р. В., Мамутова А. В., Чомахидзе А. М., Маянский Н. А., Ткаченко Н. Е.
Вопросы современной педиатрии
Т. 18, Вып. 2, С. 101-108
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.15690/vsp.v18i2.2012
Аннотация:
International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. High efficiency and safety of pneumococcal vaccines in children with SJIA is presented. Numerous researches show the adequate immune response after vaccination as well as alongside with genetically engineered biologic drugs therapy. Prevention of pneumococcal disease in patients with SJIA reduces the risk of development of pneumococcal diseases severe complications. © 2019 Publishing House of the Union of Pediatricians. All rights reserved.
Ключевые слова:
Biologic therapy; Children; Efficiency; Genetically engineered biologic drugs; Pneumococcal disease; Prevention; Safety; Systemic juvenile idiopathic arthritis; Vaccination
biological product; Pneumococcus vaccine; Article; biological therapy; human; immune response; pneumococcal infection; risk reduction; systemic juvenile idiopathic arthritis; vaccination
Язык текста: Русский
ISSN: 1682-5535
Алексеева Е. И. Екатерина Иосифовна 1962-
Ван’кова Д. Д.
Солошенко М. А.
Дворяковская Т. М. Татьяна Маратовна 1975-
Исаева К. Б.
Денисова Р. В.
Мамутова А. В.
Чомахидзе А. М.
Маянский Н. А. Николай Андреевич 1972-
Ткаченко Н. Е.
Alekseeva E. I. Ekaterina Iosifovna 1962-
Van’kova D. D.
Soloshenko M. A.
Dvoryakovskaya T. M. Tat`yana Maratovna 1975-
Isaeva K. B.
Denisova R. V.
Mamutova A. V.
Chomahidze A. M.
Mayanskij N. A. Nikolay Andreevich 1972-
Tkachenko N. E.
Pneumococcal vaccine in patients with systemic juvenile idiopathic arthritis receiving biologic therapy: International practice review [Вакцинация против пневмококковой инфекции пациентов с системным ювенильным идиопатическим артритом, получающих биологическую терапию: обзор международного опыта]
Pneumococcal vaccine in patients with systemic juvenile idiopathic arthritis receiving biologic therapy: International practice review [Вакцинация...
Текст визуальный непосредственный
Вопросы современной педиатрии
Издательство "Педиатръ"
Т. 18, Вып. 2 С. 101-108
2019
Статья
Biologic therapy Children Efficiency Genetically engineered biologic drugs Pneumococcal disease Prevention Safety Systemic juvenile idiopathic arthritis Vaccination
biological product Pneumococcus vaccine Article biological therapy human immune response pneumococcal infection risk reduction systemic juvenile idiopathic arthritis vaccination
International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. High efficiency and safety of pneumococcal vaccines in children with SJIA is presented. Numerous researches show the adequate immune response after vaccination as well as alongside with genetically engineered biologic drugs therapy. Prevention of pneumococcal disease in patients with SJIA reduces the risk of development of pneumococcal diseases severe complications. © 2019 Publishing House of the Union of Pediatricians. All rights reserved.